Novel Phenyldiazenyl Fibrate Analogues as PPAR α/γ/δ Pan-Agonists for the Amelioration of Metabolic Syndrome
作者:Letizia Giampietro、Antonio Laghezza、Carmen Cerchia、Rosalba Florio、Lucia Recinella、Fabio Capone、Alessandra Ammazzalorso、Isabella Bruno、Barbara De Filippis、Marialuigia Fantacuzzi、Claudio Ferrante、Cristina Maccallini、Paolo Tortorella、Fabio Verginelli、Luigi Brunetti、Alessandro Cama、Rosa Amoroso、Fulvio Loiodice、Antonio Lavecchia
DOI:10.1021/acsmedchemlett.8b00574
日期:2019.4.11
The development of PPARα/γ dual or PPARα/γ/δ pan-agonists could represent an efficacious approach for a simultaneous pharmacological intervention on carbohydrate and lipid metabolism. Two series of new phenyldiazenyl fibrate derivatives of GL479, a previously reported PPARα/γ dual agonist, were synthesized and tested. Compound 12a was identified as a PPAR pan-agonist with moderate and balanced activity
PPARα/γ双重或PPARα/γ/δ泛激动剂的发展可能代表一种同时进行药理干预碳水化合物和脂质代谢的有效方法。合成并测试了两个系列的新的GL479苯基二氮烯基贝特酸酯衍生物(先前报道的PPARα/γ双激动剂)。化合物12a被鉴定为对三种PPAR亚型(α,γ,δ)具有中等且平衡活性的PPAR泛激动剂。此外,对接实验表明,与PPARα或PPARδ相比,12a在PPARγ中采用不同的结合方式,为进一步的PPAR泛激动剂结构指导设计提供了结构基础。在体外均评估了12a的有益作用,关于PPAR靶向关键代谢基因的表达,以及离体在两种大鼠组织炎症模型中的作用。所获得的结果使得可以认为该化合物是开发新型PPAR泛激动剂的有趣线索,所述PPAR泛激动剂具有可用于代谢综合症治疗的活化特性。